Investcorp Credit Management BDC, Inc. Schedules Earnings Release for Second Quarter and Fiscal Period Ended December 31, 2024
About Investcorp Credit Management BDC, Inc.
The Company is an externally-managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940. The Company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation by investing in debt and related equity investments of privately held middle-market companies. The Company seeks to invest primarily in middle-market companies that have annual revenues of at least $50 million and earnings before interest, taxes, depreciation, and amortization of at least $15 million. The Company's investment activities are managed by its investment adviser, CM Investment Partners LLC. To learn more about Investcorp Credit Management BDC, Inc., please visit www.icmbdc.com.
Forward-Looking Statements
Statements included herein or on the conference call may contain 'forward-looking statements,' which relate to future performance or ICMB's financial condition, are based upon current expectations and are inherently uncertain. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance condition or results and involve a number of assumptions, risks and uncertainties and other factors, some of which are beyond the Company's control, including the impact of significant market volatility on the Company's business, its portfolio companies, its industry and the global economy. Actual results may differ materially from those anticipated in any forward-looking statements as a result of a number of factors, including those described from time to time in filings by the Company with the Securities and Exchange Commission. The Company undertakes no duty to update any forward-looking statement made herein, except as required by law. All forward-looking statements speak only as of the date of this press release.
SOURCE: Investcorp Credit Management BDC, Inc.
Copyright Business Wire 2025.
PUB: 03/21/2025 10:18 PM/DISC: 03/21/2025 10:18 PM
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
27 minutes ago
- Business Wire
Energy Dome Inks a Strategic Commercial Agreement with Google
MILAN, Italy--(BUSINESS WIRE)--Energy Dome, a pioneering company setting the benchmark for long-duration energy storage, has announced a global commercial partnership with Google using Energy Dome's CO2 Battery technology to enable carbon-free energy for the grids that power Google's operations. Alongside the commercial agreement, Google has made a strategic investment in Energy Dome. Why Energy Dome and Google are partnering Electricity is key to modern life and prosperity. This is increasingly relevant as the energy system is electrified, and economic growth drives new electricity demand, including from computational needs of artificial intelligence and data centers. Solar and wind are amongst the most cost-effective and rapid ways of delivering capacity to the grid, but are inflexible due to their inherent intermittency. Long-duration energy storage resolves this flexibility constraint by storing solar and wind energy and dispatching it later when needed. For energy users such as Google, this technology enables 'firm' electricity to meet demand in a reliable, clean, and cost-effective way. Google's first commercial long-duration energy storage deal is part of a growing portfolio of advanced energy technologies needed to realize its ambition to run its operations on 24/7 carbon-free energy by 2030. The selection of Energy Dome's proven and market-ready CO2 Battery technology reflects its ability to be deployed at the scale, speed and affordability required on a global basis. The CO2 Battery is capable of continuously dispatching energy for periods of 8 to 24 hours, unlocking enough firm electricity to meet both the baseload and flexibility requirements of large energy users. The modular, site-independent product design uses off-the-shelf equipment without supply chain bottlenecks, ensuring a highly scalable solution to store massive amounts of energy efficiently and cost-effectively. Furthermore, the mechanical components of the technology help stabilize the grid by providing natural inertia from rotating machinery. This is especially important given the concurrent ramp-up of solar and wind (which lack inertia) with the ramp-down of legacy fossil-fuel power stations, whose inertia is lost when the plants are decommissioned. The CO2 Battery thus contributes to maintaining grid resiliency by acting as a shock absorber to smooth out sudden changes in frequency. "Google is committed to powering our operations with clean energy, and Energy Dome's technologically proven and scalable long-duration energy storage solution can help us unlock rapid progress,' said Maud Texier, Director of EMEA Energy at Google. 'But this isn't just about Google. By helping to scale this first-of-a-kind LDES technology, we hope to help communities everywhere gain greater access to reliable, affordable electricity and support grid resilience as we integrate more renewable energy sources.' The commercial agreement aims to develop CO2 Battery projects in all the key geographical strategic areas, including Europe, America, and the Asia-Pacific region, with the goal of scaling up deployment at a rapid pace to meet Google's 2030 carbon-free energy goals. A pipeline of sites and projects has been identified in the partnership, which are currently in development and contracting stages. 'The programmatic and strategic deployment of our technology at scale to help Google reach carbon-free energy represents the core of our industry-first agreement. We're proving that a 24/7 cost-effective and carbon-free energy supply is achievable with the right technology and partnership model,' said Claudio Spadacini, Founder and CEO of Energy Dome. ' We are also pleased to welcome Google as an investor in Energy Dome, underlining our joint commitment to a shared vision.' Investment Alongside Commercial Alliance Beyond the commercial collaboration, Google has also made an investment in Energy Dome. The investment coincides with the company entering a growth phase of commercial deployment, and multiple projects already contracted, including with Alliant Energy in the U.S., Engie in Italy, and NTPC in India. By investing directly in the Milan-based scaleup, Google is reinforcing its long-term commitment to accelerating the commercialization of this proven technology. As a pioneer in the first generation of corporate power purchase agreements when solar and wind were in their infancy, Google brings both the customer perspective and experience to enhance the maturation and commercial scaling of CO2 Battery technology, unlocking adoption benefits for communities and economies. About Energy Dome Energy Dome is at the forefront of redefining long-duration energy storage with its CO2 Battery. The properties of carbon dioxide allow the system to store energy efficiently and cost-effectively through a patented thermo-mechanical process, hence representing the most valid alternative to lithium-ion batteries or pumped-hydro solutions. The CO2 Battery is already a fully validated and cost-effective system that uses no lithium or rare-earth elements to store electricity, boasting superior round-trip efficiency. With a modular approach and site-independent footprint, CO2 Batteries use readily available, off-the-shelf components from reliable, existing supply chains, providing a scalable pathway to store massive amounts of intermittent renewable energy and accelerate the energy transition; it's the only technology available today offering the right combination of efficiency, cost, scalability and that's viable globally. For more information, please visit
Business Wire
27 minutes ago
- Business Wire
Almirall H1 2025 Results
BARCELONA, Spain--(BUSINESS WIRE)-- Almirall, S.A. (ALM) a global biopharmaceutical company based in Barcelona, today announced its financial results for the first half of 2025. The company continued to deliver strong sales growth in H1 2025, primarily driven by its dermatology business in Europe. Total Net Sales increased by 12.7% to €560.5 million, while EBITDA increased by 16.6% year-on-year to €121.8 million driven by higher sales growth and a gross profit of 65.5%. The European dermatology business delivered strong growth, with net sales increasing by 24.2% year-on-year to €289.5 million. Based on this solid performance, Almirall reiterates its full-year guidance for 2025 expecting double-digit net sales growth. Ebglyss®, indicated for the treatment of moderate-to-severe atopic dermatitis (AD), delivered a strong performance in H1 2025 generating approximately €45 million in net sales (>x4 YoY). The product continues to gain momentum through sustained growth in existing markets and launches in new ones. Ebglyss® delivered around €25 million in sales in Q2, becoming Almirall's second largest product just 18 months after launch. It is now reimbursed in 14 European countries, including France (since April 2025), with additional launches planned in Portugal and Ireland in the second half of the year. Ilumetri®, for the treatment of moderate-to-severe psoriasis, continues to grow consistently. The positive reception of the 200mg formulation is further contributing to the brand's performance. In Q2 2025, Ilumetri® achieved net sales of €58 million. Since the European launch in 2018, the product has shown a positive growth trajectory and remains on track to achieve peak sales exceeding €300 million. 'We continue to deliver on our ambition of sustained double-digit growth and are pleased to confirm our guidance for 2025, as well as our mid-term outlook, based on our solid results in the first half of 2025. Our performance makes us confident in achieving our long-term business ambition as a leader in medical dermatology which will enable us to help more patients with relevant and impactful treatments. The growth of our European dermatology business is driven by the strong performance of our biologics portfolio, which is rolling out successfully across Europe. Our broad portfolio in medical dermatology is performing well and is a cornerstone of our high relevance to dermatologists and patients. We continue to invest in R&D to progress our exciting pipeline. Our operational excellence, scientific expertise, and close partnership with the dermatology community are at the heart of our ongoing growth.' Carlos Gallardo, Almirall Chairman and CEO 2025 Full Year Guidance Full-year guidance reiterated: Net Sales growth of double-digit net sales growth (10-13%) and EBITDA between €220 million and €240 million. R&D pipeline Almirall continues to invest in its leading R&D capabilities, aligning its pipeline with its long-term vision of leadership in medical dermatology. In H1 2025, R&D investment increased by approximately 27% year-on-year, representing 12.8% of Net Sales. For the anti-IL-1RAP monoclonal antibody, Almirall completed Phase I single and multiple ascending doses in healthy volunteers, presenting the results at the recent AAD meeting. The antibody showed a favorable safety and tolerability profile, along with a low immunogenicity risk, supporting further development for treating immune-mediated inflammatory skin disorders. A Phase II study in Hidradenitis suppurativa is planned for later this year. Almirall has recently expanded its collaboration with Simcere, to discover and develop multispecific antibodies to generate significantly better therapeutic options for patients suffering from auto-immune skin diseases. This collaboration increases Almirall's access to relevant R&D activities in China as one of the leading territories for innovation in life sciences. Partnership with the dermatology community Almirall's close collaboration with dermatologists and life-science experts remains a cornerstone of its success in medical dermatology. In addition to hosting the 16th Skin Academy in Barcelona in March, Almirall had significant presence in major events such as the 2025 Annual AAD Meeting, 11th World Congress of Melanoma, 21st EADO Congress, and most recently, the 2025 International Congress of Dermatology (ICD) in Rome. These partnerships reinforce Almirall's commitment to fostering scientific exchange and advancing the understanding of skin diseases, treatment options, and their impact on patients. Investor Calendar 2025 Q3 2025 Financial Results – 10th November 2025 About Almirall Almirall is a global pharmaceutical company dedicated to medical dermatology. We closely collaborate with leading scientists, healthcare professionals, and patients to deliver our purpose: to transform the patients' world by helping them realize their hopes and dreams for a healthy life. We are at the forefront of science to deliver ground-breaking, differentiated medical dermatology innovations that address patients´ needs. Almirall, founded in 1944 and headquartered in Barcelona, is publicly traded on the Spanish Stock Exchange (ticker: ALM, total revenue in 2024: €990 MM, over 2000 employees globally). Almirall products help to improve the lives of patients every day and are available in over 100 countries. For more information, please visit Legal notice: This document includes only summary information and is not intended to be exhaustive. The facts, figures, and opinions contained in this document, in addition to the historical ones, are "forward-looking statements." These statements are based on the information currently available and the best estimates and assumptions that the Company considers reasonable. These statements involve risks and uncertainties beyond the control of the Company. Therefore, actual results may differ materially from those declared by such forward-looking statements. The Company expressly waives any obligation to revise or update any forward-looking statements, goals, or estimates contained in this document to reflect any changes in the assumptions, events, or circumstances on which such forward-looking statements are based, unless required by the applicable law.
Business Insider
42 minutes ago
- Business Insider
3 Small-Cap Stocks Rated ‘Strong Buy' With Over 60% Upside Potential
In a choppy market, investors continue to look for stocks with high conviction from Wall Street. The three companies below each earn a Strong Buy consensus and offer over 60% upside based on average analyst price targets. They operate in cloud infrastructure, cybersecurity, and crypto services sectors, where analysts focus on execution and growth potential. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Let's take a look. Backblaze Price: $5.49 | Market Cap: $301.4 million | Avg. Price Target: $9.00 | Upside: 63.9% Backblaze (BLZE) provides cloud backup and storage solutions for individuals, businesses, and developers. The stock rose more than 20% over the past three months but remains down 8% year-to-date. Analyst sentiment is positive, with four Buy ratings in the past three months. The highest price target is $11.00, while the average is $9.00, suggesting over 60% upside. Backblaze reported $34.6 million in revenue last quarter, up from $30.0 million a year ago. Analysts highlight steady growth and pricing differentiation as key positives for the company's B2 Cloud Storage platform. Qoria Price: $0.19 | Market Cap: $449.4 million | Avg. Price Target: $0.38 | Upside: 100.0% The next one is a promising penny stock company named Qoria (FMZNF), formerly Family Zone Cyber Safety, which offers digital safety tools for schools and families. The company's Family Zone platform is used across Australia, the United Kingdom, the United States, and other international markets. The stock has traded flat for the past quarter and is down 44.1% year-to-date. Still, all four analysts covering Qoria rate it a Buy. The average price target is $0.38, double its current price. Analysts highlight the company's position in education and telecom safety, noting recurring interest from institutions focused on regulated technology sectors. Exodus Movement, Inc. Price: $34.21 | Market Cap: $987.7 million | Avg. Price Target: $58.83 | Upside: 71.9% Exodus Movement, Inc. (EXOD) develops a non-custodial crypto wallet that supports multiple digital assets. The stock is down 24.8% over the past three months but has gained nearly 11% year-to-date. Analyst coverage is consistent, with six Buy ratings and no Hold or Sell ratings. The average price target is $58.83, with a high of $65.00. Analysts suggest that regulatory developments, including the CLARITY Act and the GENIUS Act, could foster stablecoin adoption and promote cross-chain wallet usage. These trends are seen as favorable for Exodus's long-term positioning in the crypto software market.
